Homegrown drugmaker, PE firm among suitors for Samara Capital’s pharma platform
Advertisement

Homegrown drugmaker, PE firm among suitors for Samara Capital’s pharma platform

By Joseph Rai

  • 11 Mar 2021
Premium
Homegrown drugmaker, PE firm among suitors for Samara Capital’s pharma platform
Credit: Thinkstock

Samara Capital’s pharma platform has received interest from the country’s top drug maker and a ...

This is a Premium article, Subscribe to read the full story!

Limited Time Offer - Subscribe now & get free access to The Unicorn report.

The year 2021 was a record year for Unicorn activity in India, with 47 new Unicorns being added to the list, from a previous 11 in 2020. Get access to exclusive analysis on growth landscape, sectoral view, future Unicorns & more..

Advertisement
Advertisement